Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000638117 | SCV000759602 | likely benign | Parathyroid carcinoma | 2023-12-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002358796 | SCV002656081 | likely benign | Hereditary cancer-predisposing syndrome | 2020-08-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002483814 | SCV002776095 | uncertain significance | Hyperparathyroidism 1; Parathyroid carcinoma; Hyperparathyroidism 2 with jaw tumors | 2021-12-16 | criteria provided, single submitter | clinical testing |